Patch-free Occlusion Therapy for Amblyopia
This study is looking at a new way to treat amblyopia (sometimes called "lazy eye") in children aged 3 to 12 years old. It compares two treatments: "Patch-free occlusion therapy," which uses special filters in glasses, and the usual "Adhesive patch" treatment. The goal is to see if the patch-free method works better to improve vision and if children stick with it more easily. To join, children need to have amblyopia and a specific difference in vision between their eyes. The study will measure changes in vision after 12 weeks to see which treatment is more successful. The current status of this study is unclear.
- Study design
- This is a randomized clinical trial involving 68 participants. Children will be randomly assigned to either the patch-free occlusion therapy or the standard adhesive patch treatment.
- What's involved
- Participants will use their assigned treatment at home for 12 weeks. Vision will be checked at 6 weeks and all initial tests will be repeated at 12 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Some participants may have the option to continue treatment and have their vision reassessed at 18 and 24 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Patch-free Occlusion Therapy
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in amblyopic eye visual acuity measured with a logMAR visual acuity chart12 weeks
change in logMAR relative to baseline